Alternative to warfarin approved in Scotland

pradaxa Pradaxa has been approved by the Scottish Medicines Consortium

Up to 40,000 people in Scotland who are at risk of stroke due to an irregular heartbeat can now be prescribed an alternative to warfarin.

Warfarin has been the main blood-thinning treatment for 50 years but has common side effects.

Pradaxa is now available to patients in Scotland but it has yet to be approved for use in England and Wales.

Although Pradaxa is more expensive than warfarin, the reduced need for check-ups should cut costs for the NHS.

Warfarin was first developed as a rat poison before its blood-thinning properties were realised.

Its use requires close monitoring, with patients having regular blood tests and avoiding certain foods.

Pradaxa, which has been approved by the Scottish Medicines Consortium, is expected to improve the treatment of people at risk of blood clots due to atrial fibrillation - the most common disorder of the heart rhythm in the UK.

More on This Story

The BBC is not responsible for the content of external Internet sites

BBC Edinburgh, Fife and East



Min. Night 10 °C


BBC © 2014 The BBC is not responsible for the content of external sites. Read more.

This page is best viewed in an up-to-date web browser with style sheets (CSS) enabled. While you will be able to view the content of this page in your current browser, you will not be able to get the full visual experience. Please consider upgrading your browser software or enabling style sheets (CSS) if you are able to do so.